Zobrazeno 1 - 7
of 7
pro vyhledávání: '"Erika Puente"'
Bempegaldesleukin plus nivolumab in first-line renal cell carcinoma: results from the PIVOT-02 study
Autor:
Mario Sznol, Adi Diab, Jonathan Zalevsky, Ute Hoch, Mehmet A Bilen, Giovanni Grignani, Nizar M Tannir, Erika Puente, Arjun V Balar, Daniel C Cho, Arlene O Siefker-Radtke, Lily Tang, David Chien, Arkopal Choudhury, Danni Yu, Sue L Currie, Mary A Tagliaferri, Michael E Hurwitz
Publikováno v:
Journal for ImmunoTherapy of Cancer, Vol 10, Iss 4 (2022)
Externí odkaz:
https://doaj.org/article/b068e058e3794225a3c64c98a9d5c726
Autor:
Mario Sznol, Adi Diab, Brendan Curti, Igor Puzanov, Gregory Daniels, Jonathan Zalevsky, Ute Hoch, Mary Tagliaferri, Michael Hurwitz, Scott Tykodi, Michele Maio, Sekwon Jang, Tuan Nguyen, Wei Lin, Karl Lewis, Alexander Spira, Ewa Kalinka, Daniel Cho, Shanhong Guan, Erika Puente, Sue Currie
Publikováno v:
Journal for ImmunoTherapy of Cancer, Vol 8, Iss Suppl 3 (2020)
Externí odkaz:
https://doaj.org/article/784e64ffc23649d48d6469271e5284e6
Autor:
Arlene O. Siefker-Radtke, Daniel C. Cho, Adi Diab, Mario Sznol, Mehmet A. Bilen, Arjun V. Balar, Giovanni Grignani, Erika Puente, Lily Tang, David Chien, Ute Hoch, Arkopal Choudhury, Danni Yu, Sue L. Currie, Mary A. Tagliaferri, Jonathan Zalevsky, Michael E. Hurwitz, Nizar M. Tannir
Publikováno v:
European Urology. 82:365-373
Despite recent changes in the treatment landscape, there remains an unmet need for effective, tolerable, chemotherapy-free treatments for patients with advanced/metastatic urothelial carcinoma (mUC), especially cisplatin-ineligible patients.To evalua
Bempegaldesleukin plus nivolumab in first-line renal cell carcinoma: results from the PIVOT-02 study
Autor:
Nizar M Tannir, Daniel C Cho, Adi Diab, Mario Sznol, Mehmet A Bilen, Arjun V Balar, Giovanni Grignani, Erika Puente, Lily Tang, David Chien, Ute Hoch, Arkopal Choudhury, Danni Yu, Sue L Currie, Mary A Tagliaferri, Jonathan Zalevsky, Arlene O Siefker-Radtke, Michael E Hurwitz
Publikováno v:
Journal for immunotherapy of cancer. 10(4)
BackgroundImmune checkpoint inhibitor-based combinations have expanded the treatment options for patients with renal cell carcinoma (RCC); however, tolerability remains challenging. The aim of this study was to evaluate the safety and efficacy of the
Publikováno v:
Acta neurochirurgica. Supplement. 109
Both awake craniotomy under conscious sedation and use of intraoperative MRI can increase the efficiency and safety of glioma resections. In contrast to craniotomies under general anesthesia, neurosurgery under conscious sedation requires several cha
Autor:
Noelia Geribaldi-Doldán, Cecilia Fernández-Ponce, Roberto Navarro Quiroz, Ismael Sánchez-Gomar, Lorena Gómez Escorcia, Erika Puentes Velásquez, Elkin Navarro Quiroz
Publikováno v:
Frontiers in Oncology, Vol 10 (2021)
Glioblastoma (GB), the most aggressive malignant glioma, is made up of a large percentage of glioma-associated microglia/macrophages (GAM), suggesting that immune cells play an important role in the pathophysiology of GB. Under physiological conditio
Externí odkaz:
https://doaj.org/article/1f603fd394b445ebafd33ec2c1c2a54d
Publikováno v:
Infancias Imágenes, Vol 16, Iss 1, Pp 83-92 (2017)
El presente artículo es producto de una exploración investigativa en curso, adelantada por el semillero de investigación Leidy Tabares (Leta), adscrito a la Licenciatura en Pedagogía Infantil de la Universidad Distrital Francisco José Caldas. Es
Externí odkaz:
https://doaj.org/article/fddf7e8e0fca423ea7e8a58a4cf4cf05